Number of Shares
150,142.00
Current Holdings Value*
$23.40 Mil
% of Portfolio
1.67%
Total Estimate Gain
$32.26 Mil
% of Total Estimate Gain
25.13%

Vestal Point Capital, LP's Ascendis Pharma AS Holding Summary

As of 2025-03-31, Vestal Point Capital, LP held 150,142.00 shares of Ascendis Pharma AS(ASND), totaling $23.40 Mil. This investment constitutes 1.67% of their stock portfolio, and Vestal Point Capital, LP now holds 0.25% of the outstanding Ascendis Pharma AS(ASND) stock.

The initial trade took place in 2023Q4. And since then Vestal Point Capital, LP has made 2 purchases of ASND, at an average price of $114.61, for a total of 1.12 Mil shares. In addition, there have been 3 sales at an average price of $138.82 for 969,858.00 shares. Based on historical transaction data and ASND's current price of $173.10, Vestal Point Capital, LP's estimated gain on his ASND holdings is $32.26 Mil, reflecting a 25.13% gain to date.

Vestal Point Capital, LP ASND ($173.10) Holding Chart

Vestal Point Capital, LP ASND ($173.10) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1